Newsroom
Sorted by: Latest
-
Vestis Appoints Russell Tiejema as Chief Financial Officer and Reiterates Fiscal Full-Year 2026 Financial Outlook
ATLANTA--(BUSINESS WIRE)--Vestis Corporation (NYSE: VSTS) (“Vestis” or the “Company”), a leading provider of uniforms and workplace supplies, today announced the appointment of Russell Tiejema as Executive Vice President and Chief Financial Officer, effective September 28, 2026. Mr. Tiejema succeeds Adam K. Bowen, who has served as Interim Chief Financial Officer since December 16, 2025. To ensure a smooth transition, Mr. Bowen intends to remain with the Company through the end of October befor...
-
AN2 Therapeutics Announces Extension of Funding for Tuberculosis Research Collaboration with GSK
MENLO PARK, Calif.--(BUSINESS WIRE)--AN2 Therapeutics, Inc. (Nasdaq: ANTX), a clinical stage pharmaceutical company focused on the discovery and development of small molecule therapeutics derived from its boron chemistry platform, today announced that the Gates Foundation has awarded an extension of funding to support AN2 Therapeutics' research activities under its ongoing tuberculosis (TB) research collaboration with GSK focused on the development of boron-based leucyl-tRNA synthetase (LeuRS)...
-
Contamination Protection Solution Highlights Covalon’s Presence at the Association for Vascular Access 2026 Annual Scientific Meeting
MISSISSAUGA, Ontario--(BUSINESS WIRE)--Covalon Technologies Ltd. (the “Company” or “Covalon”) (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its participation at the Association for Vascular Access (AVA) Annual Scientific Meeting in Grapevine, Texas, from October 2 to 4, 2026, with pre-meeting workshops on October 1. Attendees will have the opportunity to explore Covalon’s innovative vascular access and infection prevention solutions and learn why leading h...
-
Cox Capital Announces Tender Offers for Class I Shares of Apollo Debt Solutions BDC and Ares Strategic Income Fund
CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Cox Capital has commenced two separate cash tender offers to purchase shares of ADS and ASIF, effective Sept. 25, 2026....
-
ACI Worldwide and Cognizant Demonstrate Strong Card Processing Performance on Amazon Web Services, Inc. (AWS)
OMAHA, Neb.--(BUSINESS WIRE)--ACI Worldwide (NASDAQ: ACIW), an original innovator in global payments technology, and Cognizant (NASDAQ: CTSH), a leading AI builder and technology services provider, today announced the results of joint performance testing of BASE24-eps, a foundational component of ACI’s card acquiring and issuing solutions, on AWS. Under simulated point-of-sale load, BASE24-eps sustained more than double its target transaction load for 30 minutes with no failed transactions. Acr...
-
Convatec Expands Cure™ Portfolio With Launch of Cure Aqua™, Bringing Greater Choice to People Who Catheterize
BOSTON & LONDON--(BUSINESS WIRE)--Convatec, a leading medical products and technologies company focused on solutions for the management of chronic conditions, announces the launch of Cure Aqua™ in the United States and Canada.The latest addition to Convatec’s Cure™ catheter portfolio, Cure Aqua™ is a ready-to-use hydrophilic intermittent catheter designed to support a comfortable catheterization experience while helping simplify daily routines. Developed with direct input from people who cathete...
-
Bruker Advances Functional Proteomics with Novel timsUltra AIP and timsOmni Workflows for Drug Discovery & Development and Disease Biology Research
SINGAPORE--(BUSINESS WIRE)--At the Human Proteome Organization World Congress 2026, Bruker Corporation (Nasdaq: BRKR) today announced unique new timsUltra AIP and timsOmni workflows for deeper protein-sequence coverage, targeted validation, mobility-resolved glycopeptide characterization, structural proteomics, and oligonucleotide analysis. Multi-enzyme dia-PASEF provides additional peptide information for investigations of isoforms and proteoforms, while ProteoScape workflows connect PASEF dis...
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Eurozone AlphaDEX UCITS ETF 25.09.2026 FEUZ IE00B8X9NY41 1,682,584.00 EUR 108,881,724.27 64.711 ...
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust US Large Cap Core AlphaDEX UCITS ETF 25.09.2026 FEXD.LN IE00BWTNMB87 447,144.00 USD 44,248,884.25 98.959 ...
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Emerging Markets AlphaDEX UCITS ETF 25.09.2026 FEM IE00B8X9NX34 300,002.00 USD 15,293,704.76 50.979 ...